Hundreds of adults and children with type 1 diabetes in England have been fitted with an artificial pancreas that experts say could become the “holy grail” for managing the disease, in a world-first trial on the NHS.
The groundbreaking device uses an algorithm to determine the amount of insulin that should be administered and reads blood sugar levels to keep them steady. The NHS trial has so far found the technology more effective at managing diabetes than current devices and that it requires far less input from patients.